Research Use Only. Not for human or veterinary use. Not medical advice.

RU-L37 · Immune Signaling Research

RU-L37 vial (catalog image)

RU-L37

Immune Signaling Research

Catalog code Research material Lyophilized format Single catalog presentation
Presentation

Vial sizes for laboratory supply, not a protocol.

Pricing
Sign in
Researcher pricing for approved accounts
In stock
As listed on the public catalog, Nov 17, 2026
Add to cart
0 25 50 75
51 of 100

Popularity

Moderate

Public interest index

Trending level-6% vs prior 30 days

Research: Literature Activity 9/10 · Very high (PubMed volume)

Data as of Nov 17, 2026 · Sources: Wikipedia pageviews, Reddit, X public mentions.

Measures online attention only. It is not a measure of quality, purity, efficacy, or safety.

Publications per year

Unique PubMed records grouped by publication year — a volume index, not a quality rating.

PubMed counts

Last updated Nov 17, 2026. 3,117 unique records for LL-37 OR LL37 OR "cathelicidin LL-37" OR "hCAP-18" OR hCAP18. 2026 is a partial year. The precursor name hCAP18 / hCAP-18 is included because LL-37 is the C-terminal peptide released from that precursor. The CAMP gene name alone was not used, because it would retrieve unrelated records. Source on PubMed

Key specifications

Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.

Catalog title
RU-L37 | Immune Signaling Research
Research focus
Immune Signaling Research
Also described as
LL-37 · human cathelicidin
Format
Lyophilized research peptide
Catalog status
In stock (public listing)
Presentations
10 mg vial (catalog presentation)Catalog sizes, not a protocol
Molecular formula
C205H340N60O53PubChem CID 16198951
Molecular weight
4,493PubChem average; exact mass 4,492.5821356
Receptor context
Human cathelicidin peptide released from the hCAP18 precursor; innate-immunity research contextLiterature description; research context only
Sequence
Not reproduced hereSee primary literature / PubChem
Researcher access
Sign-in required to view pricing
PubMed records
3,117 uniqueQuery above, Nov 17, 2026

Catalog notes & use limitations

Research-catalog framing only. This section does not describe effects in people or study outcomes.

Catalog notes

Listed under Immune Signaling Research

RU-L37 appears in the PEPTIDEA™ Immune & Inflammation Signaling Research collection with RC-KPV and RC-TA1.

Human cathelicidin LL-37

The catalog identity is LL-37, the human cathelicidin peptide derived from hCAP18, not a veterinary cathelicidin or a generic antimicrobial-peptide class listing.

Single catalog presentation

The public listing is a simple product. The 10 mg vial size is inferred from SKU ru-415-10 and is a presentation of the research material, not a protocol.

Use limitations

Research use only

Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.

No outcome or dosing information

This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.

Confirm details from primary sources

Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.

Specifications

Laboratory-catalog and public-chemistry details. Items without a cited source are marked.

Catalog titleRU-L37 | Immune Signaling Research
CategoryImmune Signaling Research (Immune & Inflammation Signaling Research)
Associated namesLL-37; cathelicidin LL-37; hCAP18-derived peptide
FormatLyophilized research peptide
Public catalog statusIn stock (as of Nov 17, 2026)
Catalog presentations10 mg vial (catalog presentation) — sizes of the research material, not a use protocol
Molecular formulaC205H340N60O53 (PubChem CID 16198951, retrieved Nov 17, 2026)
Molecular weight4,493 (PubChem average; exact mass 4,492.5821356)
InChIKeyPOIUWJQBRNEFGX-XAMSXPGMSA-N (PubChem)
Receptor contextPublished papers describe LL-37 as the 37-residue C-terminal peptide of hCAP18, the only human cathelicidin. That is an identity and pathway description, not a use claim.
SequenceNot reproduced on this page. See primary literature and the PubChem record.
PricingVisible after researcher sign-in
PubChem CID 16198951 is cited for formula and mass. Sequence is omitted on this page.

Research literature

These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.

Review

Zanetti

Current Issues in Molecular Biology · 2005
Cathelicidins in innate host defenses of mammals

This review surveys the role of cathelicidins, including the human peptide LL-37, in innate host-defense biology.

Host-defense inferences and any outcome figures cited in the review are not restated on this page.

Review

Zanetti

Journal of Leukocyte Biology · 2004
Cathelicidins as multifunctional peptides of innate immunity

This review surveys cathelicidins as multifunctional innate-immunity peptides, including discussion of the human peptide LL-37.

Functional inferences and any clinical-context discussion in the review are not reproduced here.

Review

Golec

Annals of Agricultural and Environmental Medicine · 2007
Survey of the human cathelicidin LL-37 as a pleiotropic innate-immunity peptide

This review surveys published work on the human cathelicidin LL-37, including laboratory studies of its interactions with bacterial lipopolysaccharide and other innate-immunity contexts.

Experimental results and any clinical inferences in the review are not restated on this page.

Review

Bucki, Leszczyńska, Namiot, and colleagues

Archivum Immunologiae et Therapiae Experimentalis · 2010
LL-37 as a multifunctional antimicrobial peptide

This review surveys the literature on cathelicidin LL-37 as a multifunctional antimicrobial peptide in innate-immunity research.

Antimicrobial or clinical inferences in the review are not reproduced here.

Review

Bandurska et al.

BioFactors · 2015
Distinct biochemical features of human cathelicidin LL-37

This review surveys distinctive biochemical and structural features of human cathelicidin LL-37 reported in the literature.

Functional claims and any disease-context discussion in the review are not restated on this page.

Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query LL-37 OR LL37 OR "cathelicidin LL-37" OR "hCAP-18" OR hCAP18. Source on PubMed

Storage & handling

General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.

  • Handle as a lyophilized research material intended for laboratory use only.
  • Store according to the conditions printed on the label and in any compound document provided to approved researchers.
  • Protect closed vials from moisture and unnecessary temperature swings.
  • If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
  • This material is not for human or veterinary use and is not medical advice.
No dosing, administration, or protocol instructions are included on this page.

Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.